1,721,411 research outputs found
Spring 2015 SOM Alumni Connections
Full text linkSchool of Medicine Alumni Association to Honor Three at Reunion Banquet NYMC Celebrates a Successful Match Day NYMC Affiliates With Good Samaritan Regional Medical Center Wilbert S. Aronow, M.D., Receives the 2014 Chancellor’s Research Award’ NYMC Welcomes New BioInc Client SHSP Launches New Programs Third Annual Saul A. Schwartz, M.D. ’30, AOA History of Medicine Visiting Professor Lecture Historical Faculty Portraits Adorn the Walls of MEC Lobby Nineteenth Annual Medical Student Research Forum Shows Breadth and Depth of Research GSRF Showcases a Broad Spectrum of Student Research NYMC is Named a Top Producer of Fulbright U.S. Scholars NYMC Grant Newshttps://touroscholar.touro.edu/nymc_som/1013/thumbnail.jp
Peripheral arterial disease in the elderly
No full textWilbert S AronowCardiology Division, Department of Medicine, New York Medical College, Valhalla, New YorkAbstract: Smoking should be stopped and hypertension, diabetes mellitus, dyslipidemia, and hypothyroidism treated in elderly patients with peripheral arterial disease (PAD) of the lower extremities. Statins reduce the incidence of intermittent claudication and improve exercise duration until the onset of intermittent claudication in patients with PAD and hypercholesterolemia. Antiplatelet drugs such as aspirin or clopidogrel, especially clopidogrel, angiotensin-converting enzyme inhibitors, and statins should be given to all elderly patients with PAD without contraindications to these drugs. Beta blockers should be given if coronary artery disease is present. Exercise rehabilitation programs and cilostazol increase exercise time until intermittent claudication develops. Chelation therapy should be avoided. Indications for lower extremity percutaneous transluminal angioplasty or bypass surgery are (1) incapacitating claudication in patients interfering with work or lifestyle; (2) limb salvage in patients with limb-threatening ischemia as manifested by rest pain, non-healing ulcers, and/or infection or gangrene; and (3) vasculogenic impotence.Keywords: peripheral arterial disease, intermittent claudication, antiplatelet drugs, statins, angiotensin-converting enzyme inhibitors, cilostazol, exercise rehabilitation, revascularizatio
Use of implantable cardioverter-defibrillators
No full text The implantable cardioverter-defibrillator (ICD) is the most effective treatment for patients with life-threatening ventricular tachycardia or ventricular fibrillation not due to reversible causes. The American College of Cardiology/American Heart Association class I and IIa indications for an ICD are discussed. Patients with ICDs who need pacing should be treated with biventricular pacing, not with dual-chamber rate-responsive pacing, at a rate of 70/min. Patients with ICDs should be treated with β-blockers, statins and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers. </jats:p
- …
